New Drug Approvals Archive - November 2016
Get news by email or subscribe to our news feeds.
See also: New Indications and Dosage Forms for November 2016
November 2016
Vemlidy (tenofovir alafenamide) Tablets
Date of Approval: November 10, 2016
Company: Gilead Sciences, Inc.
Treatment for: Chronic Hepatitis B
Vemlidy (tenofovir alafenamide) is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease.
Intrarosa (prasterone) Vaginal Inserts
Date of Approval: November 17, 2016
Company: Endoceutics Inc.
Treatment for: Dyspareunia
Intrarosa (prasterone) is a once-daily, vaginally administered steroid indicated to treat postmenopausal women experiencing moderate to severe pain during sexual intercourse (dyspareunia) as a symptom of vulvar and vaginal atrophy.
Xultophy (insulin degludec and liraglutide) Injection - formerly IDegLira
Date of Approval: November 21, 2016
Company: Novo Nordisk
Treatment for: Diabetes Type 2
Xultophy 100/3.6 (insulin degludec and liraglutide) is a fixed-ratio combination of the long-acting basal insulin analog, insulin degludec (Tresiba), and the a glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide (Victoza), indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Soliqua 100/33 (insulin glargine and lixisenatide) Injection
Date of Approval: November 21, 2016
Company: Sanofi
Treatment for: Diabetes Type 2
Soliqua 100/33 (insulin glargine and lixisenatide) is fixed-ratio combination of the long-acting human insulin analog insulin glargine (Lantus) and the glucagon-like peptide-1 (GLP-1) receptor agonist lixisenatide (Adlyxin), indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
New Drug Approvals Archive
2019January, February, March, April, May, June, July, August, September
2018January, February, March, April, May, June, July, August, September, October, November, December
2017January, February, March, April, May, June, July, August, September, October, November, December
2016January, February, March, April, May, June, July, August, September, October, November, December
2015January, February, March, April, May, June, July, August, September, October, November, December
2014January, February, March, April, May, June, July, August, September, October, November, December
2013January, February, March, April, May, June, July, August, September, October, November, December
2012January, February, March, April, May, June, July, August, September, October, November, December
2011January, February, March, April, May, June, July, August, October, November, December
2010January, February, March, April, May, June, July, August, September, October, November, December
2009January, February, March, April, May, June, July, August, September, October, November, December
2008January, February, March, April, May, June, July, August, September, October, November, December
2007January, February, March, April, May, June, July, August, September, October, November, December
2006January, February, March, April, May, June, July, August, September, October, November, December
2005January, February, March, April, May, June, July, August, September, October, November, December
2004January, February, March, April, May, June, July, August, September, October, November, December
2003January, February, March, April, May, June, July, August, September, October, November, December
2002January, February, April, May, July, August, October, November, December
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
